Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Monoclonal antibodies raised against Xenopus p53 interact with human p73

Abstract

The p53 tumor suppressor gene belongs to a multigene family that includes two paralogues, p63 and p73. The structure of the p63 and p73 genes is quite similar, but both have common activities with p53, such as DNA binding and transactivation. Both p53 and p73 bind to mdm2, but only p53 is degraded through the activity of mdm2. p63 neither binds to nor is degraded by mdm2 despite important conservation in the key interacting residues. Using a panel of monoclonal antibodies raised against human and Xenopus p53, we have been able to find several antibodies that cross-react strongly with human p73. These antibodies react both with exogenous p73 expressed in mammalian cells and with endogenous p73. Interestingly, all these antibodies react with the same epitope localized in the amino-terminus of p53, but have no cross-reaction with p63. This epitope corresponds to the exact mdm2 binding site to p53. These antibodies inhibit the interaction between either p53 or p73 and mdm2, and may be useful tools for the study of these proteins. Furthermore, our studies suggest that there exist specific spatial requirements for the interaction between p53 or p73 and mdm2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bensaad K, Rouillard D, Soussi T . 2001 Oncogene 20: 3766–3775

  • Ikawa S, Nakagawara A, Ikawa Y . 1999 Cell Death Differ. 6: 1154–1161

  • Kojima T, Ikawa Y, Katoh I . 2001 Biochem. Biophys. Res. Commun. 281: 1170–1175

  • Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP . 1996 Science 274: 948–953

  • Legros Y, Lafon C, Soussi T . 1994a Oncogene 9: 2071–2076

  • Legros Y, Meyer A, Ory K, Soussi T . 1994b Oncogene 9: 3689–3694

  • Levine AJ . 1997 Cell 88: 323–331

  • Little NA, Jochemsen AG . 2001 Oncogene 20: 4576–4580

  • Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin Jr WG . 1998 Mol. Cell. Biol. 18: 6316–6324

  • Portefaix J, Thebault S, Bourgain-Guglielmetti F, Del Rio M, Granier C, Mani J, Navarro-Teulon I, Nicolas M, Soussi T, Pau B . 2000 J. Immunol. Methods 244: 17–28

  • Soussi T, Dehouche K, Béroud C . 2000 Hum. Mutat. 15: 105–113

  • Tominaga O, Unsal K, Zalcman G, Soussi T . 2001 Br. J. Cancer 84: 57–63

  • Vojtesek B, Dolezalova H, Lauerova L, Svitakova M, Havlis P, Kovarik J, Midgley CA, Lane DP . 1995 Oncogene 10: 389–393

  • Wang X, Arooz T, Siu WY, Chiu CH, Lau A, Yamashita K, Poon RY . 2001 FEBS Lett. 490: 202–208

  • Yang A, McKeon F . 2000 Nature cell biology 1: 199–207

Download references

Acknowledgements

We thank J Bram for critical reading of the manuscript. We are grateful to D Caput, S Ikawa and S Picksley for reagents and to Y Lherieau and C Quetard for BIAcore facilities. This work was supported by grants from the Ligue Nationale contre le Cancer (Comité de Paris) and the Association pour la Recherche contre le Cancer (ARC). M Le Bras is supported by the Ministère de l'Education Nationale et de la Recherche and K Bensaad by a fellowship from the Ligue Nationale contre le Cancer (Comité National).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thierry Soussi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Le Bras, M., Delattre, V., Bensaad, K. et al. Monoclonal antibodies raised against Xenopus p53 interact with human p73. Oncogene 21, 1304–1308 (2002). https://doi.org/10.1038/sj.onc.1205189

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205189

Keywords

This article is cited by

Search

Quick links